a great place for cancer research - Recensione dipendente - Dipendente anonimo presso Genentech

3,0
23 gen 2011
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

research orientated; most people are very friendly; a lot of resources; decent salary and great benefit; good cancer drug development

Svantaggi

there is very little career perspective. No hope for promotion or advancement. Genentech is becoming a big Pharma so comes along all the cons

Esplora altre recensioni su Genentech

5,0
6 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Great salary and team! The interview process was smooth and effective.

Svantaggi

To be determined, but so far many alignment meetings. Some folks have frustuations around the re-org and strategy changes.

3,0
7 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Genentech's origin story and mission are genuinely inspiring — few companies can point to such a meaningful historical arc in medicine. Patient engagement is taken seriously and feels authentic, not performative. The campus is beautiful and the culture has real warmth.

Svantaggi

DDA is operating with significant gaps. First, the foundational data infrastructure is not mature enough to support the ambitions being set for the team. Second, the measurement culture has gotten ahead of the methodology, and no one in a position of authority seems to be asking hard questions about whether the numbers actually mean what they're being presented as meaning. Third, some management feel disconnected from the work itself, lacking the knowledge, hands-on experience, or relevant credentials. Individually any one of these would be manageable. Together these create an environment where it's hard to do rigorous work, rather work is performative, and be recognized for it.

2
Vedi recensioni per: Utile|Valutazione|Data|Tutto